Gland Pharma Ltd (GLAND) — Announcement | 30 September 2026
Gland Pharma Ltd announced that its trading window closes on October 1, 2026, ahead of the unaudited Q2 results release, restricting insider trading until 48 hours post-results announcement. This routine procedural filing restricts insider trading activity before financial results disclosure.
About Gland Pharma Ltd (GLAND)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when GLAND files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GLAND — Free💡 Ask AI about this filing
📊 More GLAND filings
- 🔴 Corporate Action — 1 October 2026Gland Pharma announced on October 1, 2026, that its board approved a USD 21 million investment in Gl...
- 🟡 Board Meeting — 1 October 2026Gland Pharma announced a $21 million investment in Gland Pharma USA Inc. to acquire a 60% stake in N...
- 🟡 Board Meeting — 1 October 2026Gland Pharma announced the outcome of its board meeting held on October 1, 2026, approving a USD 21 ...
- 🔴 Corporate Action — 13 September 2026Gland Pharma announced on September 13, 2026, that its board approved acquiring 100% of Gland Pharma...
- 🔴 Corporate Action — 13 September 2026Gland Pharma announced the allotment of 42,393 equity shares under ESOP 2025 and 1,800 shares under ...
🔥 Also filed on 30 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when GLAND files new disclosures
Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GLAND — FreeFree account · 2 AI queries/day